Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection.

Satoskar AA, Pelletier R, Adams P, Nadasdy GM, Brodsky S, Pesavento T, Henry M, Nadasdy T.

Am J Transplant. 2010 Aug;10(8):1804-11. doi: 10.1111/j.1600-6143.2010.03178.x.

2.

Pathology of C4d-negative antibody-mediated rejection in renal allografts.

Haas M.

Curr Opin Organ Transplant. 2013 Jun;18(3):319-26. doi: 10.1097/MOT.0b013e32835d4daf. Review.

PMID:
23283250
3.

The significance of C4d staining with minimal histologic abnormalities.

Haas M.

Curr Opin Organ Transplant. 2010 Feb;15(1):21-7. doi: 10.1097/MOT.0b013e3283342ebd. Review.

PMID:
19907328
4.

Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.

Niikura T, Yamamoto I, Nakada Y, Kamejima S, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Yamada H, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.

Nephrology (Carlton). 2015 Jul;20 Suppl 2:75-8. doi: 10.1111/nep.12467. Review.

PMID:
26031592
5.

The importance of C4d in biopsies of kidney transplant recipients.

CorrĂªa RR, Machado JR, da Silva MV, Helmo FR, GuimarĂ£es CS, Rocha LP, Faleiros AC, dos Reis MA.

Clin Dev Immunol. 2013;2013:678180. doi: 10.1155/2013/678180. Epub 2013 Jul 9. Review.

6.

Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.

Sis B, Halloran PF.

Curr Opin Organ Transplant. 2010 Feb;15(1):42-8. doi: 10.1097/MOT.0b013e3283352a50. Review.

PMID:
20009933
8.

Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.

Choi J, Cho YM, Yang WS, Park TJ, Chang JW, Park SK.

Clin Transplant. 2007 Mar-Apr;21(2):159-65. Review.

PMID:
17425739
9.

A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection.

Sapir-Pichhadze R, Curran SP, John R, Tricco AC, Uleryk E, Laupacis A, Tinckam K, Sis B, Beyene J, Logan AG, Kim SJ.

Kidney Int. 2015 Jan;87(1):182-94. doi: 10.1038/ki.2014.166. Epub 2014 May 14. Review.

PMID:
24827778
10.

Currently available useful immunohistochemical markers of renal pathology for the diagnosis of renal allograft rejection.

Kanzaki G, Shimizu A.

Nephrology (Carlton). 2015 Jul;20 Suppl 2:9-15. doi: 10.1111/nep.12460. Review.

PMID:
26031579
11.

De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.

Shochet L, Kanellis J, Simpson I, Ta J, Mulley W.

Nephrology (Carlton). 2017 Feb;22 Suppl 1:23-27. doi: 10.1111/nep.12936. Review.

PMID:
28176480
12.

A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.

Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, Goebel J, Dixon BP.

Blood Rev. 2015 May;29(3):191-204. doi: 10.1016/j.blre.2014.11.001. Epub 2014 Nov 28. Review.

13.

New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G, Laskin BL.

Transfus Apher Sci. 2016 Apr;54(2):181-90. doi: 10.1016/j.transci.2016.04.007. Epub 2016 Apr 25. Review.

PMID:
27156964
14.

Effects of CD20+ B-cell infiltration into allografts on kidney transplantation outcomes: a systematic review and meta-analysis.

Lu Y, Li B, Shen Q, Wang R, Chen Z, Jiang H, Chen J.

Oncotarget. 2017 Mar 15. doi: 10.18632/oncotarget.16229. [Epub ahead of print] Review.

15.

An update on renal involvement in hemophagocytic syndrome (macrophage activation syndrome).

Esmaili H, Mostafidi E, Mehramuz B, Ardalan M, Mohajel-Shoja M.

J Nephropathol. 2016 Jan;5(1):8-14. doi: 10.15171/jnp.2016.02. Epub 2015 Jul 15. Review.

Supplemental Content

Support Center